Search
Bicycle Therapeutics PLC
BCYCAdd to Watchlist
4.350USD
+0.140+3.33%
Close 07/02, 13:00（ET）Quotes delayed by 15 min
218.67MMarket Cap
LossP/E TTM
Shareholding Stats
Updated: Sat, May 9
Updated: Sat, May 9
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Baker Bros. Advisors LP
21.68%
Forbion Capital Partners
6.89%
Armistice Capital LLC
6.42%
Acadian Asset Management LLC
3.32%
Long Focus Capital Management LLC
3.24%
Other
58.45%
Shareholders
Shareholders
Proportion
Baker Bros. Advisors LP
21.68%
Forbion Capital Partners
6.89%
Armistice Capital LLC
6.42%
Acadian Asset Management LLC
3.32%
Long Focus Capital Management LLC
3.24%
Other
58.45%
Shareholder Types
Shareholders
Proportion
Hedge Fund
36.92%
Investment Advisor
14.08%
Investment Advisor/Hedge Fund
7.12%
Venture Capital
7.12%
Corporation
3.04%
Individual Investor
1.47%
Research Firm
1.20%
Family Office
0.53%
Pension Fund
0.51%
Other
28.02%
Institutional Shareholding
Updated: Wed, Apr 1
Updated: Wed, Apr 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2026Q1
250
33.87M
67.23%
-23.14M
2025Q4
242
39.22M
114.58%
+31.05K
2025Q3
266
40.06M
126.53%
-4.18M
2025Q2
264
44.22M
123.05%
-338.39K
2025Q1
249
44.93M
127.83%
-16.05M
2024Q4
249
44.97M
130.44%
+273.71K
2024Q3
245
43.83M
123.27%
+876.01K
2024Q2
237
43.44M
106.75%
+5.72M
2024Q1
253
34.16M
113.53%
-14.25M
2023Q4
258
34.56M
124.36%
-3.64M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Baker Bros. Advisors LP
10.92M
21.73%
+38.00K
+0.35%
Jan 02, 2026
Forbion Capital Partners
3.47M
6.9%
+16.10K
+0.47%
Dec 31, 2025
Armistice Capital LLC
3.24M
6.44%
+258.00K
+8.66%
Dec 31, 2025
Acadian Asset Management LLC
1.67M
3.32%
+356.70K
+27.13%
Dec 31, 2025
Long Focus Capital Management LLC
1.63M
3.25%
+214.40K
+15.11%
Dec 31, 2025
Invus Public Equities Advisors, LLC
3.15M
6.26%
+1.14M
+56.45%
Feb 25, 2026
GSK plc
1.53M
3.04%
+1.53M
--
Dec 31, 2025
Principal Global Investors (Equity)
1.15M
2.28%
-130.00
-0.01%
Dec 31, 2025
T. Rowe Price Associates, Inc.
1.17M
2.33%
-213.01K
-15.38%
Dec 31, 2025
Schroder Investment Management Ltd. (SIM)
584.77K
1.16%
+584.77K
--
Dec 31, 2025
View more
Related ETFs
Updated: Sat, Dec 6
Updated: Sat, Dec 6
Name
Proportion
Virtus LifeSci Biotech Clinical Trials ETF
0.63%
Invesco NASDAQ Future Gen 200 ETF
0.59%
Harbor Health Care ETF
0.23%
ALPS Medical Breakthroughs ETF
0.17%
iShares Health Innovation Active ETF
0.05%
Invesco Nasdaq Biotechnology ETF
0.04%
ProShares Ultra Nasdaq Biotechnology
0.04%
SPDR S&P International Small Cap ETF
0.03%
iShares Biotechnology ETF
0.02%
ActivePassive International Equity ETF
0%
View more
Virtus LifeSci Biotech Clinical Trials ETF
Proportion0.63%
Invesco NASDAQ Future Gen 200 ETF
Proportion0.59%
Harbor Health Care ETF
Proportion0.23%
ALPS Medical Breakthroughs ETF
Proportion0.17%
iShares Health Innovation Active ETF
Proportion0.05%
Invesco Nasdaq Biotechnology ETF
Proportion0.04%
ProShares Ultra Nasdaq Biotechnology
Proportion0.04%
SPDR S&P International Small Cap ETF
Proportion0.03%
iShares Biotechnology ETF
Proportion0.02%
ActivePassive International Equity ETF
Proportion0%